Pricing Log in Create free account

BioMarin Pharmaceutical Inc. (BMRN) vs Summit Therapeutics PLC (SMMT)

BioMarin Pharmaceutical Inc. and Summit Therapeutics PLC are both Biotechnology companies. BioMarin Pharmaceutical Inc. and Summit Therapeutics PLC are of similar size ($11.3B and $10.9B). BioMarin Pharmaceutical Inc. grew revenue faster over the last twelve months: 18.1% against −61.0%. Summit Therapeutics PLC has the higher net margin (0.00% vs −0.52%) and the lower return on invested capital (0.00% vs 0.73%). Across the 19 metrics below, BioMarin Pharmaceutical Inc. leads on 14 and Summit Therapeutics PLC on 5.

Valuation

Metric BMRN SMMT Biotechnology median
P/E n/m n/m 10.26
P/S 2.97 15,883.80 9.18
P/B 1.74 17.78 2.05
Price to free cash flow 19.96 n/m 24.81
EV/EBITDA 38.25 n/m 0.65
EV/Sales 3.91 15,045.51 8.98
Earnings yield (0.17%) (7.78%) (34.89%)
Free cash flow yield 5.01% (4.11%) (24.52%)

Profitability

Metric BMRN SMMT Biotechnology median
Gross margin 75.95% 100.00% 65.16%
Operating margin 3.12% 0.00% 0.00%
Net margin (0.52%) 0.00% 0.00%
Free cash flow margin 15.26% 0.00% 0.00%
Return on equity (0.31%) (192.50%) (50.12%)
Return on assets (0.20%) (159.09%) (45.60%)
Return on invested capital 0.73% 0.00% 0.00%

Growth

Metric BMRN SMMT Biotechnology median
Revenue growth (TTM) 18.14% (61.03%) 6.26%
EPS growth (last fiscal year) (18.55%) (364.52%) 29.88%
Revenue growth, 5-year CAGR 11.60% (46.49%) 9.75%
Net income growth, 5-year CAGR (16.39%) 0.00% 0.00%

Health

Metric BMRN SMMT Biotechnology median
Debt to equity 0.67 0.00 0.00
Current ratio 2.44 6.96 4.89
Net debt to EBITDA (1.99) 0.65 1.01

Dividend

Metric BMRN SMMT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BMRN SMMT Biotechnology median
Market cap 10.87b 11.32b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack